NCT06525597View on ClinicalTrials.gov

Study of Stapokibart Injection in Patients With Allergic Rhinitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

October 30, 2025

Study Completion Date

October 30, 2025

Conditions
Allergic Rhinitis
Interventions
BIOLOGICAL

Stapokibart Injection

IL-4Rα monoclonal antibody

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

RECRUITING

Beijing Tongren Hospital, CMU, Beijing

Sponsors
All Listed Sponsors
lead

Keymed Biosciences Co.Ltd

INDUSTRY

NCT06525597 - Study of Stapokibart Injection in Patients With Allergic Rhinitis | Biotech Hunter | Biotech Hunter